Attendees who purchased access to the 2016 Annual Meeting webcast were sent login information on May 11, 2016.

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 51 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 48 49 50 51 presentations: 1 to 25 of 1260
Antibodies and Nanoparticles for Targeted Radiotherapy to Cancer
Molecular radiotherapy: Intracellular targets and delivery
Katherine A Vallis
Univ. of Oxford, Oxford, United Kingdom
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Antibodies and Nanoparticles for Targeted Radiotherapy to Cancer
Nanotechnology In Radiation Oncology
Andrew Z. Wang
University of North Carolina at Chapel Hill, Durham, NC, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Antibodies and Nanoparticles for Targeted Radiotherapy to Cancer
Conventional and Pretargeted Radioimmunotherapy for B Cell Lymphomas
Damian Green
Fred Hutchinson Cancer Research Ctr., Seattle, WA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Antibodies and Nanoparticles for Targeted Radiotherapy to Cancer
AntibodiesTargeted to Radiation Inducible Antigens in Cancer
Dennis E. Hallahan
Washington University School of Medicine, St. Louis, MO, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Tumor Immunology and Immunotherapy for Non-Immunologists: How Tumors Regulate Immune Responses
Inhibiting immune checkpoints
Mary L. Disis
University of Washington, Seattle, WA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Tumor Immunology and Immunotherapy for Non-Immunologists: How Tumors Regulate Immune Responses
Regulatory T cells
Dario A. Vignali
Univ. of Pittsburgh School of Medicine, Pittsburgh, PA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Tumor Immunology and Immunotherapy for Non-Immunologists: How Tumors Regulate Immune Responses
Regulatory myeloid cells
Dmitry I. Gabrilovich
The Wistar Institute, Philadelphia, PA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Tumor Immunology and Immunotherapy for Non-Immunologists: How Tumors Regulate Immune Responses
Galectins and immune response in cancer
Gabriel A. Rabinovich
Instituto de BiologĂ­a y Medicina Experimental, CONICET, Ciudad de Buenos Aires, Argentina
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Bioinformatics in Personalized Cancer Genomics: From Sequencing Data to Clinical Actionability
Chairperson
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Bioinformatics in Personalized Cancer Genomics: From Sequencing Data to Clinical Actionability
Facilitating precision oncology through enterprise-level data sharing in the clinical laboratory: Lessons from 10,000 samples
Ahmet Zehir
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Bioinformatics in Personalized Cancer Genomics: From Sequencing Data to Clinical Actionability
MI-ONCOSEQ precision medicine tumor boards: Linking clinicians with integrated cancer genomics
Dan Robinson
University of Michigan, Ann Arbor, MI, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Bioinformatics in Personalized Cancer Genomics: From Sequencing Data to Clinical Actionability
Making complex genomics data accessible to clinicians and researchers through the cBioPortal for Cancer Genomics and other tools
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Bioinformatics in Personalized Cancer Genomics: From Sequencing Data to Clinical Actionability
Optimizing the dissemination and implementation of precision cancer medicine through health services research
Stacy W. Gray
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Biomarkers for Cancer Immunotherapy
Multiplex IHC as biomarkers for cancer immunotherapy
Paul C Tumeh
UCLA Medical Center, Los Angeles, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Biomarkers for Cancer Immunotherapy
Tumor DNA sequencing as biomarkers for cancer immunotherapy
Eliezer Van Allen
Dana Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Biomarkers for Cancer Immunotherapy
Mutational clonality and intratumor heterogeneity as biomarkers for cancer immunotherapy
Nicholas McGranahan
The Francis Crick Institute, London, United Kingdom
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Biomarkers for Cancer Immunotherapy
Identification and evaluation of neoantigen-specific T cells as biomarkers for cancer immunotherapy
Pia Kvistborg
Netherlands Cancer Inst., Amsterdam, Netherlands
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Breast Cancer Targets in 2016
Introduction
Lisa A. Carey
UNC Lineberger Comp. Cancer Center, Chapel Hill, NC, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Breast Cancer Targets in 2016
Targeted therapy for ESR1 positive breast cancer
Matthew J. Ellis
Baylor College of Medicine Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Breast Cancer Targets in 2016
Targeting HER2/3 in breast cancer: An overview of genomic changes, drug development and clinical trials
Ron Bose
Washington Univ. School of Medicine, Saint Louis, MO, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Breast Cancer Targets in 2016
Targeting DNA repair
James M. Ford
Stanford University, Stanford, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Breast Cancer Targets in 2016
Resistance to P13K inhibitors: A problem or an opportunity?
Maurizio Scaltriti
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Emerging Targets for the Treatment of Lung Cancer
Resistance to targeted therapies in lung adenocarcinoma
Mark Awad
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Emerging Targets for the Treatment of Lung Cancer
Emerging targets in lung adenocarcinoma
Eric A. Collisson
UCSF, San Francisco, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Emerging Targets for the Treatment of Lung Cancer
Treatment advances in squamous cell lung cancer and immunotherapy in NSCLC
Esra A Akbay
DFCI, Boston, MA, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
<< first | < prev page: of 51 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 48 49 50 51 presentations: 1 to 25 of 1260